Eddie Enever - Holistic Health Expert

08/10/2026

This is the kind of news that makes all the difficult days feel worthwhile. ❤️

This patient has endured chemotherapy, treatment, side effects, fear and uncertainty, while embracing an integrative approach to support her health.

And now, a remarkable milestone.

Her latest circulating tumour cell and stem-cell assessment found:

✅ No live EpCAM-positive circulating cells above the detection limit.

✅ ZERO detectable growth of EpCAM-positive stem cells in culture.

An incredibly encouraging result!

Conventional scans cannot reliably detect microscopic residual disease. Emerging technologies like Maintrac/Stemtrac offer another window into this landscape, including whether circulating cells demonstrate stem-cell-like growth.

The science is evolving. We don’t yet know precisely how these findings predict recurrence, and a negative result cannot guarantee cancer is gone.

But science isn’t finished. There’s still so much to discover.

And there’s another benefit worth discussing.

Psychological safety.

Anyone who’s survived cancer knows the fear.

A swollen lymph node. An unfamiliar pain. Unexplained fatigue.

Your child has a virus, your immune system responds, but your mind screams:

“It’s back.”

Encouraging results like these can offer reassurance alongside ongoing surveillance, even though new symptoms still need appropriate assessment.

After 16 years in integrative cancer care, I remain passionate about bringing the best approaches together.

Not conventional oncology OR integrative care. BOTH.

Treat the cancer while supporting the whole person through nutrition, metabolic health, movement, sleep and nervous-system regulation.

We cannot attribute this result to any single intervention.

But we can celebrate the incredible woman who has worked so hard to get here.

A bloody fantastic result. ❤️

The monitoring continues. And so does living.

🎀

25/09/2026

I’ll be speaking at this amazing event. Come visit!!

03/09/2026

After seven years of fighting cancer… ZERO circulating cancer stem cells.

This one is huge.

This patient has been dealing with prostate cancer for around seven years.

Years of aggressive treatment.
Years of appointments and interventions.
Around $2 million spent on his care.

Cancer — and treating cancer — has consumed an enormous part of his life.

When we met, one of the questions I wanted us to answer wasn’t:

“What else can we do?”

It was:

“How will we know when we’ve done enough?”

Because after years of treatment, continuing to fight can become its own form of safety.

Doing something feels safe.
Stopping feels terrifying.

So rather than continuing to treat a disease based purely on the fear that something might remain, we tested.

His MAINTRAC test still detected a small population of circulating EpCAM-positive potential tumour cells.

But when those cells were cultured to look for circulating cancer stem cells capable of clonal expansion…

ZERO.

No growth of circulating cancer stem cells was detected.

That doesn’t mean one test declares someone cured.

It doesn’t mean monitoring stops. We’ll be repeating the test and watching carefully.

But for the first time in years, we have objective information that allows us to ask whether the intensity of treatment still matches the evidence of disease.

And perhaps begin doing something incredibly important:

Giving this man his life back.

Because sometimes testing tells us we need to do more.

But it should also help us recognise when it may be appropriate to start doing less.

There are two freedoms worth working towards in cancer care:

Freedom from disease.

And eventually…

freedom from having to live every day as though you still have it.

After seven years of fighting, perhaps the next chapter isn’t about fighting harder.

Perhaps it’s about carefully finding his way back to living.

28/08/2026

This is one of those results that means far more than the numbers on the page.

This patient has worked incredibly hard for years to get here.

His journey began with Stage 4 sigmoid adenocarcinoma in 2021. Since then, there has been surgery, chemotherapy, ongoing treatment, repeated testing, setbacks, improvements, plateaus and plenty of moments where the result we wanted still felt just out of reach.

But he kept going.

And now, finally:

Circulating tumour cells: below the laboratory’s detection limit.

Circulating cancer stem cells: ZERO.

Even more significantly, no cancer stem cell growth was detected during cultivation, meaning no cells with detectable potential for clonal expansion were identified.

This is what I mean when I talk about working towards microscopic remission.

A clear scan or NED is enormously important, but one of the deeper questions can still be:

What remains at the microscopic level?

This testing gives us another piece of that puzzle.

It doesn’t replace scans, oncology care or routine monitoring, and it doesn’t mean we stop watching. We continue to forge forward and solidify the results.

But today, we celebrate.

Because this result has not come easily.

It has come through persistence, commitment, patience and a willingness to keep showing up even when progress was slower than hoped.

That little zero represents years of work.

And for someone who has fought this hard to reach it, it is anything but small.

Congratulations mate. You earned this moment.

18/08/2026

A huge moment to celebrate.

Two more recent CTC / CSC results have come through showing 0 detectable circulating cancer stem cells.

And over the past few weeks, I’ve had a number of these “zeros” coming back.

Every time I see one, I pause.

Because behind that result is not just a lab report.

It’s a person. A family. A diagnosis. Treatment. Fear. Uncertainty. Discipline. Courage. And an enormous amount of work.

This is why testing matters.

In cancer care, we rely heavily on scans, tumour markers, pathology and the words “no evidence of disease.”

All are important.

But they don’t necessarily tell us everything about what may remain at the microscopic level.

Circulating tumour cell and circulating cancer stem cell testing can provide another layer of information.

Not a replacement for oncology care.
Not a guarantee.
Not a crystal ball.

But another way of asking:

What evidence do we have that treatment has been effective beyond what we can see on a scan?

Are there signs of residual systemic activity?

And if someone has been actively working towards reducing minimal residual disease — the potential “leftovers” after treatment — what has changed?

That’s where retesting becomes so valuable.

It allows us to move from guessing towards measuring.

Sometimes the next step is monitoring. Sometimes consolidation. Sometimes it’s continuing active work towards deeper microscopic clearance.

And sometimes the result comes back:

0 detectable circulating cancer stem cells.

That deserves to be celebrated.

Not because the journey is suddenly over, or because any single test provides certainty.

But because it provides another piece of evidence to help guide what comes next.

To the people behind these results — I see the work you’re putting in.

Today, we celebrate.

This is why we test.
This is why we track.
This is why we build a plan.

Because in cancer care, clarity changes everything.

09/08/2026

I had the pleasure of chatting with Branchy again in the topic of cancer, cancer care, the downfall of modern oncology and the role of connection in disease, health and healing. It was a deep one!!!

Listen here:

https://open.spotify.com/episode/3r5jHC0rDvx1BjM0qV9O5g?si=DNemqpLUTvKMTVPCfV15-w&utm_source=copy-link

09/08/2026

There is still time to give yourself an evening to slow down.

This Tuesday, Yin and Tea will bring together mindfulness, a mindful tea ceremony, 90 minutes of deeply restorative Yin Yoga and curated medicina music in one small, intimate experience.

The evening has been created around presence.

Around softening the pace.

Around stepping out of constant doing and returning to the body, the breath and the moment in front of you.

Only 10 people will share this space, and just a small number of places remain.

Tuesday 11 August
7:00 pm–9:30 pm
The Inspiration Space, Inglewood

Comment YIN below and I will send you the event details so you can secure one of the final spots.

07/08/2026

THIS is a result worth celebrating.

I received this follow-up result from one of my patients today, and I couldn’t be happier for her.

At the end of her conventional treatment, testing had identified circulating tumour cells and circulating cancer stem cells.

She could have finished treatment and simply waited for the next scan.

Instead, she chose to keep working.

She committed to the strategy. She followed her protocols. She made the nutritional and lifestyle changes. She worked on her metabolic health. She supported her body consistently. She kept showing up.

And now we have her follow-up results.

Circulating tumour cells: below the detection limit of the assay.

Circulating cancer stem cells: ZERO detected.

That 0 circled on this report means a great deal to me.

Does it mean we can declare that cancer can never return? No. Biology doesn’t give us guarantees like that, and no single blood test can.

But is this an incredibly encouraging result worth stopping and celebrating?

Absolutely.

Because this is what taking agency can look like.

Cancer care doesn’t have to end with “treatment is finished — now we wait.”

There is still an opportunity to ask:

What can I influence?

What can I measure?

How can I support my health and recovery?

What can I do consistently that puts me in the strongest position possible moving forward?

There is no magic bullet here.

There is strategy, consistency and a person willing to do the work.

And today, that work is accompanied by a result she should be incredibly proud of.

ZERO circulating cancer stem cells detected.

Huge congratulations. This is your moment. Enjoy it.

And then, as always, we keep going.

Prognosis is not destiny.

06/08/2026

05/08/2026

Most people know curcumin as the golden compound found in turmeric.

What they often do not realise is how many of cancer’s survival systems it may influence.

Curcumin has been studied for its effects on inflammation, growth signalling, cancer-cell metabolism, treatment resistance and stem-like cancer cells. Within a Press–Pulse strategy, it may be especially valuable as part of the sustained press that makes cancer less comfortable, less adaptable and less able to recover.

But curcumin is not simple.

Its formulation matters. Its timing matters. Its poor absorption matters. And turmeric in food is not the same as a concentrated curcumin intervention.

My new article explores where curcumin may fit within metabolic oncology, what the research actually shows, and why it is far more interesting than a yellow spice in a jar.

Comment CURCUMIN below and I’ll send you the full article.